Article: African Americans respond poorly to hepatitis C treatment.

2004 JUN 21 - (NewsRx.com & NewsRx.net) -- African Americans have a significantly lower response rate to treatment for chronic hepatitis C than non-Hispanic whites, according to a new study led by Duke University Medical Center researchers.

Some African Americans - 19% - did respond to the drug combination of peginterferon alfa-2b and ribavirin. But in non-Hispanic whites with the same disease, the hepatitis C genotype 1 virus strain, 52% had no evidence of the virus in their blood 6 months after completing the drug therapy - one of the highest response rates ever reported for this therapy. The study showed the difference in infection rates between the two groups ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!